Wello Inc.

We are committed to breaking a century-long paradigm in how temperature is used to detect diseases and, more importantly, prevent their spread through innovative AI technology. Our FDA Class II non-contact medical device, powered by WelloAI, detects potential infections before symptoms show—or even if they don’t. This proactive approach enables organizations to significantly reduce infection risks and absenteeism. Since our founding in 2014, Wello has rapidly evolved into a leader in AI-driven health solutions, backed by a passionate team committed to making a meaningful impact in workplaces and communities. Join us in transforming health management and creating safer spaces for everyone through the capabilities of WelloAI.